Compare BAND & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAND | CERT |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2017 | 2020 |
| Metric | BAND | CERT |
|---|---|---|
| Price | $46.93 | $10.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $67.00 | $9.17 |
| AVG Volume (30 Days) | 837.3K | ★ 2.6M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | $204,113,000.00 | ★ $418,838,000.00 |
| Revenue This Year | $20.41 | N/A |
| Revenue Next Year | $7.46 | $2.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.26 | 8.75 |
| 52 Week Low | $12.50 | $4.45 |
| 52 Week High | $79.08 | $11.88 |
| Indicator | BAND | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 65.04 |
| Support Level | $46.46 | $6.15 |
| Resistance Level | $56.74 | N/A |
| Average True Range (ATR) | 4.58 | 0.54 |
| MACD | 0.24 | 0.12 |
| Stochastic Oscillator | 53.05 | 68.99 |
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of its revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.